Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Paying user area
Try for free
HCA Healthcare Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Common Stock Valuation Ratios
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2011
- Return on Equity (ROE) since 2011
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to HCA Healthcare Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Long-term Activity Ratios (Summary)
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
The analysis of the quarterly financial data reveals several trends related to asset utilization and turnover ratios over the observed periods.
- Net Fixed Asset Turnover
- The net fixed asset turnover ratio shows a gradual decline from 2.45 in the first quarter of 2018 to approximately 2.26 by the end of 2019. This decline suggests a reduced efficiency in generating sales from fixed assets during this period. However, from 2020 onwards, the ratio stabilizes and demonstrates a slight upward trend, reaching about 2.46 by the first quarter of 2022. This recovery indicates improved utilization of fixed assets in recent quarters.
- Net Fixed Asset Turnover Including Operating Lease (Right-of-Use Assets)
- When including operating lease right-of-use assets, the ratio starts at a similar level to the net fixed asset turnover in early 2018 but decreases more sharply to around 2.08 by early 2019. This reflects the impact of leasing obligations on asset efficiency metrics. The ratio remains relatively stable through 2020 before showing a modest increase to approximately 2.27 by the first quarter of 2022. This implies a gradual improvement in managing both owned and leased assets for revenue generation.
- Total Asset Turnover
- Total asset turnover experiences a slight downward trend from around 1.19 in early 2018 to about 1.10 by the first quarter of 2019. It fluctuates modestly thereafter, with a noticeable dip to approximately 1.00 in the middle of 2020, possibly reflecting external challenges during that period. Following this low, the ratio improves moderately, stabilizing near 1.14 by the start of 2022. This movement illustrates some volatility in overall asset efficiency but a general recovery towards previous levels.
- Equity Turnover
- Data for equity turnover is sparse, with values reported only in certain quarters of 2021, notably a high figure around 213.15. The absence of data for other periods precludes a comprehensive trend analysis. The isolated high values might indicate unusual transactions or changes in equity base during those quarters.
Overall, asset turnover ratios depict a period of decline in asset utilization efficiency through 2018 and 2019, followed by stabilization and gradual improvement post-2020. The inclusion of operating leases moderates some of the efficiency metrics but reflects a similar directional pattern. The total asset turnover’s dip around mid-2020 may relate to broader economic or operational disruptions. Limited equity turnover data restricts further interpretation in that area.
Net Fixed Asset Turnover
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Revenues | |||||||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||||||
| Long-term Activity Ratio | |||||||||||||||||||||||
| Net fixed asset turnover1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Net Fixed Asset Turnover, Competitors2 | |||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q1 2022 Calculation
Net fixed asset turnover
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Property and equipment, net
= ( + + + )
÷ =
2 Click competitor name to see calculations.
- Revenue Trends
- Revenues showed a general upward trend from March 2018 through March 2022. Starting at $11,423 million in March 2018, they increased steadily, peaking at $15,276 million in September 2021. There was a notable dip in the second quarter of 2020 down to $11,068 million, likely reflecting temporary disruptions. After this dip, revenues recovered and surpassed previous highs, reaching over $15 billion in late 2021 before a slight decline to $14,945 million in March 2022.
- Property and Equipment, Net
- The net value of property and equipment consistently increased throughout the period analyzed. Beginning at $18,124 million in March 2018, the figure rose to $24,228 million by March 2022. This steady increase indicates ongoing investments in fixed assets, with minor fluctuations but no significant declines throughout the years.
- Net Fixed Asset Turnover Ratio
- The net fixed asset turnover ratio exhibited a gradual decline from 2.45 in March 2018 to a low of 2.17 in June 2020, reflecting a decrease in revenue generated per unit of fixed assets. Following this low, the ratio improved steadily, reaching 2.46 by March 2022, indicating better utilization of fixed assets in generating revenue. The ratio's trend mirrors fluctuations in revenues relative to the growth in property and equipment values.
- Overall Analysis
- Over the observed period, the company demonstrated steady growth in revenues coupled with continuous investment in property and equipment. The temporary decline in revenues and asset turnover ratio around mid-2020 suggests an external impact affecting operations. Subsequent recovery indicates resilience and improved asset efficiency. The increase in net fixed asset turnover towards the end of the period points to enhanced operational effectiveness in leveraging fixed assets to drive revenues.
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
HCA Healthcare Inc., net fixed asset turnover (including operating lease, right-of-use asset) calculation (quarterly data)
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q1 2022 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset)
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Property and equipment, net (including operating lease, right-of-use asset)
= ( + + + )
÷ =
- Revenues
- Revenues exhibit a generally increasing trend over the analyzed periods from March 31, 2018, to March 31, 2022. Starting at approximately 11,423 million US dollars, revenues rose steadily with some fluctuations, reaching a peak near 15,276 million US dollars in the fourth quarter of 2021 before slightly declining to 14,945 million US dollars by the first quarter of 2022. A noticeable dip occurs during the mid-2020 period, likely reflecting external adverse conditions, but the recovery thereafter is marked and sustained.
- Property and Equipment, Net (Including Operating Lease, Right-of-Use Asset)
- The net value of property and equipment demonstrates a consistent upward trajectory throughout the quarters. Beginning at about 18,124 million US dollars in March 2018, this asset base expanded continuously, reaching approximately 26,366 million US dollars by the first quarter of 2022. There is no significant decline or plateau observed, indicating ongoing investment and capital expenditure in property and equipment assets across the period.
- Net Fixed Asset Turnover (Including Operating Lease, Right-of-Use Asset)
- The net fixed asset turnover ratio shows a declining trend from 2.45 in March 2018 to around 2.08 by the end of 2019. The ratio then further decreases to a low of approximately 2.01 in mid-2020, coinciding with a period of revenue volatility. Subsequently, the ratio gradually improves, reaching approximately 2.27 by March 2022. This suggests initial reduced efficiency in generating revenues from fixed assets, followed by a recovery and enhanced asset utilization towards the end of the period.
- Summary of Key Insights
- The overall pattern indicates growth in revenue and asset base, reflecting expansion and capital investment efforts. The dip in revenue in 2020 corresponds temporally with the lowest net fixed asset turnover ratio, implying challenges in operational efficiency or demand during that period. The recovery in net fixed asset turnover alongside rising revenues post-2020 reflects improved efficiency and effective asset management in the latter quarters. The steady increase in property and equipment suggests a commitment to maintaining and expanding infrastructure to support business operations.
Total Asset Turnover
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Revenues | |||||||||||||||||||||||
| Total assets | |||||||||||||||||||||||
| Long-term Activity Ratio | |||||||||||||||||||||||
| Total asset turnover1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Total Asset Turnover, Competitors2 | |||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q1 2022 Calculation
Total asset turnover
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Total assets
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The financial data reveals several notable trends over the analyzed periods. Revenues exhibited a general upward trajectory from early 2018 through early 2022, with some fluctuations. The revenue figures increased from approximately 11,423 million US dollars in the first quarter of 2018 to a peak exceeding 15,000 million US dollars by late 2021, before showing a slight decline by the first quarter of 2022.
Total assets consistently increased throughout the period, indicating asset growth within the organization. Starting around 37,299 million US dollars in the first quarter of 2018, total assets rose steadily, surpassing 52,000 million US dollars by the first quarter of 2022. This growth trend suggests ongoing investment or accumulation of resources.
Regarding total asset turnover, which is a measure of how efficiently assets generate revenues, the ratio showed some variability but generally declined from early 2018 to mid-2020. It started near 1.19-1.21 in 2018, decreased to a low point around 1.00 by the third quarter of 2020, and then recovered somewhat afterward. The recovery brought the ratio back to approximately 1.14 by early 2022, although it remained below the higher levels observed in the earlier years.
- Revenues
- Overall growth with periodic fluctuations, peaking in late 2021.
- Decline observed in 2020 amid broader volatility, possibly linked to external disruptions.
- Recovery and further growth resumed into late 2021 before a slight decline in early 2022.
- Total Assets
- Steady and continuous increase over the entire period, indicating asset accumulation or expansion.
- No significant declines, confirming a consistent growth strategy or retained capital.
- Total Asset Turnover
- Moderate decline from 2018 through mid-2020, suggesting reduced asset use efficiency during that timeframe.
- Partial recovery starting in late 2020, but levels remain below the highest ratios seen in 2018.
- The decline and recovery pattern may reflect operational or market conditions affecting asset productivity.
In summary, the company demonstrated solid asset growth and a general increase in revenues, although the efficiency of asset utilization experienced a noticeable dip, particularly in 2020. The partial rebound in asset turnover ratio alongside revenue recovery indicates efforts to enhance operational efficiency following a period of challenges. These trends should be monitored for implications on long-term performance and capital management strategies.
Equity Turnover
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||
| Revenues | |||||||||||||||||||||||
| Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc. | |||||||||||||||||||||||
| Long-term Activity Ratio | |||||||||||||||||||||||
| Equity turnover1 | |||||||||||||||||||||||
| Benchmarks | |||||||||||||||||||||||
| Equity Turnover, Competitors2 | |||||||||||||||||||||||
| Abbott Laboratories | |||||||||||||||||||||||
| Elevance Health Inc. | |||||||||||||||||||||||
| Intuitive Surgical Inc. | |||||||||||||||||||||||
| Medtronic PLC | |||||||||||||||||||||||
| UnitedHealth Group Inc. | |||||||||||||||||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
1 Q1 2022 Calculation
Equity turnover
= (RevenuesQ1 2022
+ RevenuesQ4 2021
+ RevenuesQ3 2021
+ RevenuesQ2 2021)
÷ Stockholders’ equity (deficit) attributable to HCA Healthcare, Inc.
= ( + + + )
÷ =
2 Click competitor name to see calculations.
The quarterly financial data reveals several notable trends in revenues and stockholders’ equity over the analyzed periods.
- Revenues
-
Revenues show a general upward trajectory from the beginning of 2018 through the first quarter of 2022. Starting at approximately US$11,423 million in the first quarter of 2018, there is a gradual increase through 2019, with revenues peaking around US$13,523 million in the fourth quarter of 2019.
A notable deviation occurs in 2020 when revenues dip in the second quarter to approximately US$11,068 million, likely reflecting an external impact. The subsequent quarters of 2020 to early 2021 demonstrate a recovery and further growth, reaching a new high of roughly US$15,276 million in the third quarter of 2021. Revenue stabilizes slightly thereafter, with minor fluctuations approaching the first quarter of 2022.
- Stockholders’ Equity (Deficit) Attributable to HCA Healthcare, Inc.
-
Stockholders’ equity shows a consistent trend of negative values throughout the periods, indicating a deficit position. However, from the first quarter of 2018 to the fourth quarter of 2019, the deficit steadily decreases from about -US$6,244 million to -US$2,808 million, implying an improvement in equity position.
In 2020, the deficit narrows significantly, reaching a positive equity of approximately US$572 million by the fourth quarter, signaling a marked recovery in the company's equity base. However, this positive trend reverses over 2021 and into early 2022, with equity moving back into negative territory, reaching about -US$2,033 million by the first quarter of 2022. This suggests some financial challenges or adjustments impacting equity during this later period.
- Equity Turnover
-
Equity turnover data is limited and only available for select quarters in 2020 and 2021. The reported ratios are extremely high, with values such as 90.09 and 213.15, which may indicate anomalous calculations or reflect substantial revenue generation relative to the equity base in those quarters. The sparse data limits comprehensive trend analysis for this metric.
Overall, the company has experienced steady revenue growth with a temporary dip likely due to extraordinary events. The equity position improved significantly in 2020 but deteriorated again afterwards. This mixed financial performance across the equity and revenue lines suggests periods of strong operational performance combined with challenges impacting the balance sheet strength.